CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma

Clinical development of chimeric antigen receptor (CAR)-T-cell therapy has been enabled by advances in synthetic biology, genetic engineering, clinical-grade manufacturing, and complex logistics to distribute the drug product to treatment sites. A key ambition of the CARAMBA project is to provide cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Prommersberger, Sabrina, Reiser, Michael, Beckmann, Julia, Danhof, Sophia, Amberger, Maximilian, Quade-Lyssy, Patricia, Einsele, Hermann, Hudecek, Michael, Bonig, Halvard, Ivics, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455317/
https://www.ncbi.nlm.nih.gov/pubmed/33846552
http://dx.doi.org/10.1038/s41434-021-00254-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455317/
https://www.ncbi.nlm.nih.gov/pubmed/33846552
http://dx.doi.org/10.1038/s41434-021-00254-w

Ejemplares similares